Clinical trial Recruiting at 2 sites Interventional Ages 45 and up Women only

Effect of Esketamine on Postoperative Sleep in Postmenopausal Women

Run by Yangzhou University · NCT07315074 · Data updated 2026-11-12

This study tests whether esketamine can improve sleep after surgery in postmenopausal women.

More Circadian Rhythm trials

Quick facts

Study typeInterventional
Ages45 Years and up
SexWomen only
Enrollment164 (estimated)
SponsorYangzhou University
Academic / other
Locations2 sites (Jingjiang, Jiangsu and 1 other locations)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedAugust 31, 2026
Trial IDNCT07315074 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Postmenopausal women aged 45 or older, scheduled for elective lower-limb fracture surgery with general anesthesia, BMI 18-28, ASA I-III.

Probably not a fit

Patients with preoperative sleep disorders, psychotropic use, or allergies to esketamine may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines the effect of esketamine versus normal saline on postoperative sleep in postmenopausal women undergoing elective lower-limb fracture surgery under general anesthesia. Eligible participants are women aged 45 or older, postmenopausal for at least 12 months, with ASA I-III, and BMI 18-28. The trial focuses on sleep outcomes and circadian rhythm metrics in the early postoperative period, with esketamine as the active intervention and saline as the control. Subjects will be screened to exclude preexisting sleep disorders, psychotropic use, and other factors that could confound sleep measurements. The goal is to determine whether esketamine can stabilize circadian rhythm and improve sleep parameters after surgery.

Why it matters

Potential benefit: If successful, esketamine could improve postoperative sleep quality and circadian stability in postmenopausal women.

How similar studies have gone: Previous research in related areas suggests potential benefits of esketamine on sleep and circadian measures, but this exact postoperative sleep indication is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. American Society of Anesthesiologists (ASA) physical status I-III.
2. Aged ≥ 45 years.
3. Women with natural menopause (aged ≥ 45 years and postmenopause for more than 12 months without surgical or medical intervention) .
4. Scheduled to undergo elective lower-limb fracture surgery with an expected duration of more than 60 min under general anesthesia.
5. Body Mass Index (BMI) between 18 and 28 kg/m².

Exclusion Criteria:

1. Presence of preoperative sleep-related disorders, such as obstructive sleep apnea or restless legs syndrome.
2. History of drug or alcohol abuse or dependence.
3. Known contraindications or allergies to esketamine or other anesthetic agents.
4. Use of psychotropic medications or sex hormones within the past 3 months.
5. Shift work or taking medications affecting melatonin.
6. Severe comorbid conditions, including but not limited to uncontrolled hypertension, coronary artery disease, cardiac insufficiency, pulmonary hypertension, intracranial hypertension or elevated intraocular pressure, hyperthyroidism, severe hepatic or renal dysfunction.
7. History of cerebral infarction, intracerebral hemorrhage, or residual central nervous system deficits.
8. Impairments of language, hearing, vision, or cognitive function that would prevent completion of questionnaires or cooperation with sleep monitoring.
9. Active oral pathologies.
10. Transfer to ICU postoperatively.

Where it's running

  • Jingjiang People's Hospital Affiliated to Yangzhou University, Yangzhou University
    Jingjiang, Jiangsu, China
    Recruiting
  • The Affiliated Hospital of Yangzhou University, Yangzhou University
    Yangzhou, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.